Suchergebnisse - "Nagrial, Adnan"

PubPharm (109)

1

Brief Report : Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von McNamee, N. | Harvey, C. | Gray, L. | +19

2

Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Frentzas, S. | Austria Mislang, A. | Lemech, C. | +7

3

Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT)

enthalten in: Clinical lung cancer | 2024

von Fantoni, A. | Warburton, L. | Solomon, B. | +9

4

Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer

enthalten in: Journal of geriatric oncology | 2024

von Stevens, S. | Nindra, U. | Shahnam, A. | +10

5

Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab

enthalten in: Asia-Pacific journal of clinical oncology | 2024

von Nindra, U. | Shahnam, A. | Stevens, S. | +8

6

Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma

enthalten in: Cancers | 2024

von Pawaskar, R. | Huang, K. | Pham, H. | +9

7

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases : a registry study

enthalten in: Frontiers in oncology | 2024

von Brown, L. | Khou, V. | Brown, C. | +19

8

Feasibility of Microlearning for Improving the Self-Efficacy of Cancer Patients Managing Side Effects of Chemotherapy

enthalten in: Journal of cancer education : the official journal of the American Association for Cancer Education | 2023

von Janssen, A. | Shah, K. | Rabbets, M. | +6

9

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

enthalten in: Nature cancer | 2023

von Chitty, J. | Yam, M. | Perryman, L. | +129

10

Feasibility of Microlearning for Improving the Self-Efficacy of Cancer Patients Managing Side Effects of Chemotherapy

enthalten in: Journal of cancer education | 2023

von Janssen, A. | Shah, K. | Rabbets, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]